Morgan Stanley (NYSE:MS) was upgraded by equities research analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a note issued to investors on Tuesday. The brokerage presently has a $59.00 price target on the financial services provider’s stock. Keefe, Bruyette & Woods’ target price points to a potential upside of 9.56% from the company’s previous close.

Other research analysts have also recently issued reports about the company. J P Morgan Chase & Co set a $53.00 price target on Morgan Stanley and gave the company a “buy” rating in a research note on Friday, September 15th. Oppenheimer reiterated a “hold” rating on shares of Morgan Stanley in a research note on Tuesday, October 17th. Compass Point reiterated a “sell” rating and issued a $38.00 price target (up from $34.00) on shares of Morgan Stanley in a research note on Monday, September 25th. upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $53.00 price objective for the company in a report on Friday, September 15th. Finally, Berenberg Bank restated a “hold” rating and issued a $40.00 price objective on shares of Morgan Stanley in a report on Thursday, September 21st. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. Morgan Stanley currently has an average rating of “Buy” and an average target price of $50.89.

Shares of Morgan Stanley (NYSE MS) traded up $1.08 on Tuesday, hitting $53.85. The stock had a trading volume of 8,151,900 shares, compared to its average volume of 9,361,044. Morgan Stanley has a one year low of $40.06 and a one year high of $54.10. The company has a market cap of $95,402.84, a PE ratio of 14.62, a price-to-earnings-growth ratio of 1.24 and a beta of 1.64. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 2.68.

Morgan Stanley (NYSE:MS) last announced its quarterly earnings results on Tuesday, October 17th. The financial services provider reported $0.93 EPS for the quarter, beating the Zacks’ consensus estimate of $0.81 by $0.12. Morgan Stanley had a return on equity of 10.07% and a net margin of 16.76%. The company had revenue of $9.20 billion during the quarter, compared to analysts’ expectations of $9.05 billion. During the same period in the prior year, the company earned $0.80 EPS. Morgan Stanley’s revenue was up 3.2% compared to the same quarter last year. research analysts anticipate that Morgan Stanley will post 3.57 earnings per share for the current fiscal year.

In other Morgan Stanley news, Director Alistair Darling sold 3,850 shares of the stock in a transaction dated Friday, November 24th. The stock was sold at an average price of $49.29, for a total transaction of $189,766.50. Following the completion of the sale, the director now directly owns 14,218 shares in the company, valued at approximately $700,805.22. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Thomas Colm Kelleher sold 40,000 shares of the stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $50.59, for a total value of $2,023,600.00. Following the sale, the president now owns 692,037 shares of the company’s stock, valued at $35,010,151.83. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 85,247 shares of company stock valued at $4,284,364. Company insiders own 0.24% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its position in shares of Morgan Stanley by 1.0% during the 2nd quarter. BlackRock Inc. now owns 102,137,658 shares of the financial services provider’s stock worth $4,551,254,000 after purchasing an additional 969,461 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Morgan Stanley by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 93,483,287 shares of the financial services provider’s stock worth $4,165,615,000 after purchasing an additional 1,256,318 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of Morgan Stanley by 3.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 20,973,434 shares of the financial services provider’s stock worth $934,569,000 after purchasing an additional 654,034 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Morgan Stanley by 24.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 12,326,657 shares of the financial services provider’s stock worth $549,275,000 after purchasing an additional 2,427,130 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Morgan Stanley by 18.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 11,816,768 shares of the financial services provider’s stock worth $569,213,000 after purchasing an additional 1,828,697 shares in the last quarter. 85.60% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Morgan Stanley (MS) Upgraded to Outperform by Keefe, Bruyette & Woods” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/12/morgan-stanley-ms-upgraded-to-buy-by-keefe-bruyette-woods.html.

About Morgan Stanley

Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.

Analyst Recommendations for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.